Category - Pharma Industry News
Memo Therapeutics initiates pioneering BK virus therapy trial
NICE approves Merck’s Keytruda for adult patients with rare triple negative breast cancer
Novartis’ Kymriah receives FDA approval to treat follicular lymphoma
NRG Therapeutics receives £2.68m Innovate UK Award
NRG receives £2.68m funding boost for neurodegenerative disorders
Thousands to potentially benefit from Roche treatment for sight loss
AstraZeneca kidney inflammation treatment trial reaches dosing stage
Phase 3 trial initiated to evaluate AZ’s Saphnelo in lupus nephritis